Evaluation of polymerized rosin for the formulation and development of transdermal drug delivery system: A technical note

AAPS PharmSciTech

Volumn 6, Issue 4, 2005, Pages

  Satturwar, Prashant M ^a,b   Fulzele, Suniket V ^a,c   Dorle, Avinash K ^a  

^a RTM NAGPUR UNIVERSITY   (India)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Diltiazem hydrochloride; In vitro permeation; In vitro release; Matrix system; Polymerized rosin; Transdermal drug delivery

Indexed keywords

DILTIAZEM; POLYMER; POVIDONE; ROSIN; PLANT RESIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG RELEASE; IN VITRO STUDY; NONHUMAN; PHYSICAL CHEMISTRY; POLYMERIZATION; RAT; SKIN IRRITATION; SKIN PERMEABILITY; THIN LAYER CHROMATOGRAPHY; TRANSDERMAL PATCH; WATER ABSORPTION; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; DRUG SCREENING; INTRADERMAL DRUG ADMINISTRATION; MALE; METABOLISM; METHODOLOGY; SKIN; WISTAR RAT;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; MALE; POLYMERS; RATS; RATS, WISTAR; RESINS, PLANT; SKIN;

EID: 33645513805     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt060481     Document Type: Article

References (37)

1. Pathak YV, Shinghatgiri M, Dorle AK. In vivo performance of pentastergum coated aspirin microcapsules. J Microencapsul. 1987;4:107-110,
2. Sheorey DS, Dorle AK. Release kinetics & drugs from rosin-glycerol ester microcapsules prepared by solvent evaporation technique. J Microencapsul. 1991;8:243-246.
3. Pathak YV, Dorle AK, Rosin and rosin derivatives as hydrophobic matrix materials for controlled release of drugs. Drug Des Deliv. 1990;6:223-227.
4. Ramani CC, Puranik PK, Dorle AK. Study of rosin-maleoabietic acid as a matrix forming materials. Int J Pharm Adv. 1996;1:344-352.
5. Pathak YV, Nikore RL, Dorle AK. Study of rosin and esters as coating materials. Int J Pharm. 1985;24:351-354. DOI: 10.1016/ 0378-5173(85)90033-X
6. Ramani CC, Puranik PK, Dorle AK. Study of diabietic acid as matrix forming material. Int J Pharm. 1996;137:11-19, DOI: 10.1016/ 0378-5173(95)04268-7
7. Mandaogade PM, Deshmukh AM, Meghre VS, Dorle AK. Biodegradation studies of rosin-glycerol ester derivative. J Bioact Comp Polym. 1999;14:344-360.
8. Fulzele SV, Satturwar PM, Dorle AK. Studies on biodegradation and in vivo biocompatibility of novel biomaterials. Eur J Pharm Sci. 2003;20:53-61.
9. Chien YW. Comparative controlled skin permeation of nitroglycerin from marketed transdermal delivery systems. J Pharm Sci. 1983;72:968-970.
10. Loftsson T, Gildersleeve N, Border N. The effect of vehicle additives on the transdermal delivery of nitroglycerin. Pharm Res. 1987;4:436-444.
11. Corbo M, Liu JC, Chien YW. Bioavailability of propranolol following oral & transdermal administration in rabbits. J Pharm Sci. 1990; 79:584-587.
12. Aqil M, Sultana Y, Ali A. Matrix type transdermal drug delivery systems of metoprolol tartrate: in vitro characterization. Acta Pharm. 2003;53:119-125.
13. Williams AC, Barry BW, Penetration enhancers. Adv Drug Deliv Rev. 2004;56:603-618.
14. Bohme K. Buprenorphine in a transdermal therapeutic system - a new option. Clin Rheumatol. 2002,21:S13-S16.
15. Dhanorkar VT, Gawande RS, Gogle BB, Dorle AK. Development and characterization of rosin-based polymer and its application as a cream base. J Cosmet Sci. 2002:53:199-208.
16. Fulzele SV, Satturwar PM, Dorle AK. Polymerized rosin: novel film-forming polymer for drug delivery. Int J Pharm. 2002;249:175-184.
17. Gigante B, Jones R, Lobo AM, et. al. The structure of an abietic acid dimer. J Chem Soc Chem Commun. 1986;22:1038-1039. DOI: 10.1039/ c39860001038
18. Parkin BA, Walter H, inventors. Polymerized rosin product and method of preparation of the same. US patent 3 891 612. June 12, 1975.
19. Gupta R, Mukherjee B. Development and in vitro evaluation of diltiazem hydrochloride transdermal patches on povidone-ethyicellulose matrices. Drug Dev Ind Pharm. 2003;29:1-7.
20. Jain SK, Chaurasia MK, Sabitha M, et al, Development and characterization of transdermal drug delivery systems for diltiazem hydrochloride. Drug Deliv. 2003;10:169-177.
21. J, Langer R, Shastri VP. Novel microemulsion enhancer formulation for simultaneous transdermal delivery drophilic and hydrophobic drugs. Pharm Res. 2003;20:264-269.
22. Baichwal RW. Advances in drug delivery systems. Bombay, India: MSR foundation; 1983:136-147.
23. British Pharmacopoeia Commission. British Pharmacopoeia. Addendum 1996. London, UK: British Pharmacopoeia Commission, 1996:1761.
24. United States Pharmacopeial Convention. United States Pharmacopeia. 23rd ed. Rockville, MD: United States Pharmacopeial Convention; 1995:1796.
25. Chien YW, Valia KH. Development of a dynamic skin permeation system for long term studies. Drug Dev Ind Pharm. 1984;10:575-599.
26. Sarpotdar PP, Gaskill JL, Giannini RP. Effect of polyethylene glycol 400 on the penetration of drugs through human cadaver skin in vitro. J Pharm Sci. 1986;75:26-28.
27. Draize JH, Woodward GS, Calvery HO. Method for the study of irritation and toxicity of substances applied topically to the skin and mucus membrane. J Pharmacol Expt Therap. 1994;82:377-390.
28. Arora P, Mukherjee B. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci. 2002;91:2076-2089.
29. Sood A, Panchagnula R. Role of dissolution studies in controlled release drug delivery system. STP Pharma Sci. 1999;9:157-168.
30. Bodmeier R, Paeratakul O. Theophylline tablets coated with aqueous latexes containing dispersed pore formers. J Pharm Sci. 1990;79:925-928.
31. Megrab NA, Williams AC, Barray BW. Oestradiol permeation through human skin and silastic membrane: effects of propylene glycol and supersaturation. J Control Release. 1995;36:277-294. DOI: 10.1016/ 0168-3659(95)00062-D
32. Rao PR, Ramakrishna S, Diwan PV. Drug release kinetics from polymeric films containing propranolol hydrochloride for transdermal use. Pharm Dev Technol. 2000;5:465-472.
33. L-lysine) block copolymers. Bioconjug Chem. 1997;8:702-707.
34. Chien YW. Development of transdermal drug delivery system. Drug Dev Ind Pharm. 1987;13:589-651.
35. Johnson ME, Blankschtein D. Linger R. Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism. J Pharm Sci. 1997;86:1162-1172.
36. Burger GT, Cheryl ML. Animal care and facilities. In: Hayes AW, ed. Principals and Methods of Toxicology 2nd ed. New York NY: Raven Press Ltd. 1989;521-552
37. PR, Diwan PV. Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and domethacin for transdermal administration. Drug Dev Ind Pharm. 1998;24:327-336.